Table 2.
Multivariable analysis for mortality related to COVID-19 infection
| Feature | aOR | 95% CI | p value |
|---|---|---|---|
| (a) | |||
| Age decile | 1.6 | 1.5–1.7 | < 0.001 |
| Male sex | 1.4 | 1.2–1.6 | < 0.001 |
| CVD | 1.3 | 1.1–1.5 | < 0.001 |
| DM | 1.5 | 1.3–1.7 | < 0.001 |
| CKD | 1.9 | 1.6–2.2 | < 0.001 |
| COPD | 1.6 | 1.3–2.0 | < 0.001 |
| Cancer | 1.1 | 1.0–1.3 | 0.116 |
| Obesity | 1.5 | 1.3–1.7 | < 0.001 |
| Smoking | 0.8 | 0.7–0.9 | 0.004 |
| Sarcoidosis | 1.8 | 0.9–3.8 | 0.107 |
| (b) | |||
| Age decile | 1.6 | 1.5–1.7 | < 0.001 |
| Male sex | 1.4 | 1.2–1.6 | < 0.001 |
| CVD | 1.3 | 1.1–1.5 | < 0.001 |
| DM | 1.5 | 1.3–1.7 | < 0.001 |
| CKD | 1.9 | 1.6–2.2 | < 0.001 |
| COPD | 1.6 | 1.3–1.9 | < 0.001 |
| Cancer | 1.1 | 1.0–1.3 | 0.104 |
| Obesity | 1.5 | 1.4–1.8 | < 0.001 |
| Smoking | 0.8 | 0.7–0.9 | 0.003 |
| Sarcoidosis with moderate or severe abnormalities in pulmonary function | 7.8 | 2.4–25.8 | 0.001 |
The model was adjusted for risk factors known to associate with adverse outcomes related to COVID-19 infection and for sarcoidosis (a) or sarcoidosis accompanied by moderate or severe abnormalities in pulmonary function (b). The dependent variable for an adverse outcome is death or intubation and mechanical ventilation.
aOR adjusted odds ratio, CI confidence interval, CVD cardiovascular disease, DM diabetes mellitus, CKD chronic kidney disease, COPD chronic obstructive pulmonary disease